Omics Empower, a global life science service provider specializing in single-cell sequencing and spatial transcriptomics, announced that Xenium™ In Situ Spatial Transcriptomics services are now ...

The market is fueled by the technology’s ability to map biomolecules and cellular interactions within tissues, enabling ...

The global spatial biology market is projected to grow at a compound annual growth rate (CAGR) of approximately 15% over the ...

Advancements in spatial proteomics enable detailed tissue mapping, linking protein localization to disease mechanisms and enhancing translational research.

The most detailed atlas of tumour cells from the deadliest form of pancreatic cancer has been developed by an global team of researchers ...

Korea University College of Medicine recently hosted a special lecture by Professor Adelheid Wöhrer from the Institute of ...

With three new partnerships, 10x Genomics signals a move beyond research tools toward clinical diagnostics using its single-cell and spatial biology platforms.

Arch Biopartners is developing next-generation drug candidates that target IL-32, a cytokine implicated in diabetic kidney disease as described in Dr. Chun’s new publication. The goal is to produce a ...

Illumina, Inc. (NASDAQ:ILMN) Q4 2025 Earnings Call Transcript February 5, 2026 Illumina, Inc. beats earnings expectations.

Industry leaders outline how advances in MS, affinity platforms, sample preparation, AI-driven analysis, and data standardization are transforming proteomics. These innovations are enabling deeper and ...